Overcoming blood–brain barrier transport: Advances in nanoparticle-based drug delivery strategies

S Ding, AI Khan, X Cai, Y Song, Z Lyu, D Du, P Dutta… - Materials today, 2020 - Elsevier
The blood–brain barrier (BBB), a unique structure in the central nervous system (CNS),
protects the brain from bloodborne pathogens by its excellent barrier properties …

pH-Sensitive nanogels for drug delivery in cancer therapy

Z Li, J Huang, J Wu - Biomaterials Science, 2021 - pubs.rsc.org
As a commonly used treatment method for cancer, chemotherapy is greatly limited by the
side effects of chemotherapy drugs and the multiple drug resistance that develops …

Stimulus-cleavable chemistry in the field of controlled drug delivery

Y Xue, H Bai, B Peng, B Fang, J Baell, L Li… - Chemical Society …, 2021 - pubs.rsc.org
Stimulus-cleavable nanoscale drug delivery systems are receiving significant attention
owing to their capability of achieving exquisite control over drug release via the exposure to …

Degradable polyprodrugs: design and therapeutic efficiency

F Seidi, Y Zhong, H **ao, Y **, D Crespy - Chemical Society Reviews, 2022 - pubs.rsc.org
Prodrugs are developed to increase the therapeutic properties of drugs and reduce their
side effects. Polyprodrugs emerged as highly efficient prodrugs produced by the …

Bioresponsive drug delivery systems for the treatment of inflammatory diseases

Y Dou, C Li, L Li, J Guo, J Zhang - Journal of Controlled Release, 2020 - Elsevier
Inflammation is intimately related to the pathogenesis of numerous acute and chronic
diseases like cardiovascular disease, inflammatory bowel disease, rheumatoid arthritis, and …

Novel monomers for photopolymer networks

H Lai, X Peng, L Li, D Zhu, P **ao - Progress in Polymer Science, 2022 - Elsevier
Photopolymerization technology to transform monomers into polymer network materials has
been widely applied to enable various conventional and emerging applications such as …

Peptide-drug conjugates: a new hope for cancer management

VP Chavda, HK Solanki, M Davidson… - Molecules, 2022 - mdpi.com
Cancer remains the leading cause of death worldwide despite advances in treatment
options for patients. As such, safe and effective therapeutics are required. Short peptides …

Recent development of pH-responsive polymers for cancer nanomedicine

H Tang, W Zhao, J Yu, Y Li, C Zhao - Molecules, 2018 - mdpi.com
Cancer remains a leading cause of death worldwide with more than 10 million new cases
every year. Tumor-targeted nanomedicines have shown substantial improvements of the …

Acid-degradable lipid nanoparticles enhance the delivery of mRNA

S Zhao, K Gao, H Han, M Stenzel, B Yin, H Song… - Nature …, 2024 - nature.com
Lipid nanoparticle (LNP)–mRNA complexes are transforming medicine. However, the
medical applications of LNPs are limited by their low endosomal disruption rates, high …

Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapy

VP Chauhan, IX Chen, R Tong… - Proceedings of the …, 2019 - National Acad Sciences
Cancer-associated fibroblasts (CAFs) can either suppress or support T lymphocyte activity,
suggesting that CAFs may be reprogrammable to an immunosupportive state. Angiotensin …